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1. General Introduction 
The nuclear lamina is a fibrous structure located beneath the inner nuclear membrane that 
interacts with the nuclear pore complex (NPC), LEM (LAP2, emerin, MAN1)-domain 
proteins, which are integral proteins that are localized to the inner membrane of the 
nuclear envelope, and chromatin, thereby contributing both to nuclear structural stability 
and to regulation of chromatin organization in higher eukaryotes. The lamina is composed 
primarily of two types of lamins, A-type (lamin A/C) and B-type (lamin B1, B2) lamins, 
and lamin polypeptides have well-defined conserved domains, including an N-terminal 
head domain, a central α-helical rod domain, and a C-terminal tail domain. Both types of 
lamin proteins self-assemble into higher-order structures through multiple steps. First, the 
lamin polypeptides form a coiled-coil dimer through parallel association of two α-helical 
rod domains. Next, the lamin dimers associate in a head-to-tail fashion. Finally, 
intermediate filaments are formed by the interaction of these polymers in an antiparallel 
fashion. Although lamin A interacts with proteins involved in transcription, cell signaling 
and apoptosis, the regulatory mechanism of the interaction remains largely unknown. 
Interestingly, it is known that lamin A is modified with small ubiquitin-related modifier 
(SUMO; SUMOylation), which is well known to modulate protein-protein interaction. 
SUMOylation is a modification that SUMO molecule covalently binds to lysine within 
the consensus sequence (ѰKXE [Ѱ: hydrophobic amino acids]). SUMOylation of 
proteins can mediate novel protein-protein interactions with other proteins containing 
SUMO-interacting motifs (SIMs). The SIM is a hydrophobic motif with a loose 
consensus sequence (V/L/I-X-V/L/I-V/L/I) that interacts non-covalently with the 
hydrophobic groove of SUMO. Interestingly, lamin A contains four SIM consensus 
sequences.  
It is assumed that decrease of lamin A SUMOylation causes familial dilated 
cardiomyopathy (FDC). However, function of lamin A SUMOylation remains unknown 
and correlation between decrease of lamin A SUMOylation and FDC is not established. 
In Chapter 2, I describe possibility that decrease of lamin A SUMOylation are not a direct 
cause of FDC. In chapter 3, I describe the roles of SIM in lamin A. 
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2. Functional analysis of lamin A SUMOylation: 
  SUMOylation-defective lamin A mutant associated with dilated  
  cardiomyopathy induces cellular senescence. 
 
2-1. Summary 
Mutation of the lamin A gene causes a diverse range of diseases referred to as 
laminopathies. Because most laminopathies have a dominant inheritance pattern and 
progress gradually, cultured cells stably expressing mutant lamin A at the same level as 
the endogenous wild type cells are required for chronological analysis. In this study, I 
demonstrated that an expression system involving a lentiviral vector that carries the 
human metallothionein gene basal promoter ensures stable and basal level expression of 
proteins and is thus suitable for investigating the properties of lamin A mutants. The small 
ubiquitin-related modifier (SUMO) modification (SUMOylation)-defective E203G 
mutant that is associated with familial dilated cardiomyopathy exhibited abnormal sub-
nuclear distribution and inhibited normal localization of WT lamin A in a dominant-
negative manner. Low-level and long-term expression of the E203G mutant resulted in 
multinucleated giant cells, aberrant lipid droplet accumulation in the cytoplasm, and 
premature senescence. Expression of another SUMOylation-defective mutant (K201R) 
did not induce any phenotypes observed in cells expressing E203G. These results indicate 
that the E203G mutant may inhibit the normal functions of wild type lamin A in a 
dominant-negative manner, but a defect in SUMOylation itself may not be involved in 
disease pathogenesis. The K201R and E203G mutations decrease SUMOylation of lamin 
A. 
 
2-2. Abbreviations 
FDC, familial dilated cardiomyopathy; GRE, glucocorticoid responsive element; 
H3K9me3, histone H3 trimethylated on lysine 9; HFF, human foreskin fibroblast; hMT-
IIA, human metallothionein-IIA; LMNA, lamin A gene; NEM, N-ethylmaleimide; SA β-
gal, senescence-associated β-galactosidase; SUMO, small ubiquitin-related modifier; WT, 
wild type. 
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2-3. Introduction 
The nuclear lamina is a fibrous structure beneath the inner nuclear membrane that 
interacts with both the nuclear membrane and chromatin, thereby contributing to nuclear 
structural stability and regulation of chromatin organization. The lamina is mainly 
composed of two types of lamins, A-type (lamin A/C) and B-type (lamin B1, B2). Lamin 
polypeptides have well-defined conserved domains, including an N-terminal head domain, 
a central α-helical rod domain, and a C-terminal tail domain (Parry et al., 1986). Both 
types of lamin proteins self-assemble into higher-order structures through multiple steps. 
First, the lamin polypeptides form a coiled-coil dimer through parallel association of two 
α-helical rod domains. Next, the lamin dimers associate in a head-to-tail fashion. Finally, 
intermediate filaments are formed by the interaction of these polymers in an antiparallel 
fashion (Dechat et al., 2010). Little information is available on the interaction between 
the A- and B-type lamins, although a recent fluorescence resonance energy transfer 
experiment demonstrated that both types of lamins interact with each other both 
homotypically and heterotypically in living cells (Delbarre et al, 2006). The expression 
patterns of the A- and B-type lamins differ between tissues, and the variations and 
combinations of lamin subtypes have been shown to play important roles in the regulation 
of tissue-specific gene expression. 
   Analysis of Lmna-/- mice and Lmna-/- mouse embryonic fibroblasts showed that 
lamin A plays important roles in chromatin organization, transcription regulation, DNA 
replication, and DNA repair. Approximately 300 mutations have been mapped to human 
LMNA. These mutations are associated with a wide range of heritable human diseases, 
collectively called laminopathies, including familial dilated cardiomyopathy (FDC), 
Emery-Dreifuss muscular dystrophy, familial partial lipodystrophy, and Hutchinson-
Gilford progeria syndrome (Maraldi et al., 2010). Although several extensive 
investigations have evaluated cells with these LMNA mutations, the reason for different 
LMNA mutations causing different diseases and the precise molecular mechanisms 
underlying the lamin A-mediated regulation of various reactions in cell nuclei remain 
unclear. Defining the functions of lamin A has been difficult because fibroblasts isolated 
from patients with various laminopathies display similar phenotypes, including an 
aberrant nuclear structure, altered lamina assembly and chromatin structure, 
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downregulation of transcription, and resultant apoptosis (Broers et al., 2006). 
Furthermore, cultured cells transiently expressing mutant lamin A that is associated with 
laminopathy present a common abnormal nuclear structure and rarely exhibit any specific 
phenotype that could be attributed to each mutation. (Schreiber & Kennedy, 2013). 
Considering that most of the LMNA mutations that have been identified in patients are 
dominant mutations and that disease development takes a long time, culturing cells that 
stably express mutant lamin A at a level equivalent to that in endogenous wild type (WT) 
cells and the investigation of these cells over time is necessary. In this study, I employed 
a lentiviral vector carrying the human metallothionein-IIA promoter without the 
glucocorticoid responsive element (hMT-IIA[ΔGRE]) to ensure low-level and long-term 
expression of mutant lamin A. In this study, I investigated two lamin A mutants (K201R 
and the FDC-associated E203G), both of which carry a single amino acid substitution 
within the consensus sequence for small ubiquitin-like modifier (SUMO) modification 
(ѰKXE [Ѱ: hydrophobic amino acids]) and therefore are expected to be defective in 
SUMOylation. Indeed, previous experiments showed that lamin A is SUMOylated at 
K201 (Zhang & Sarge, 2008). Therefore, detailed analysis of cells expressing K201R 
mutation as well as E203G mutation may be important to understand direct correlation 
between the defect in SUMOylation and FDC pathogenesis. Our results revealed that both 
the K201R and E203G lamin A mutations indeed decrease SUMOylation at K201, as 
reported previously (Zhang & Sarge, 2008), but the distribution pattern in the nuclei of 
cells expressing these mutants was quite different. Moreover, only E203G lamin A 
inhibited normal localization of WT lamin A in a dominant-negative manner and 
decreased the amount of heterochromatin at the nuclear periphery. Long-term expression 
of E203G lamin A increased the accumulation of cytoplasmic lipid droplets and gradually 
induced premature senescence. Therefore, I propose that defects in lamin A SUMOylation 
are not a direct cause of FDC, but the E203 residue may be important for normal lamin A 
function. I also propose that development of a low-level and long-term expression system 
that harbors a lentivirus carrying the hMT-IIA basal promoter may be an appropriate 
approach to study late-onset laminopathies.  
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2-4. Experimental procedure 
Cell culture 
HeLa cells were cultured in Ham’s F-12 medium containing 10% fatal bovine serum 
(FBS) (Nichirei Biosciences, Tokyo, Japan) at 37°C under 5% CO2. HFF cells, a normal 
human foreskin fibroblast line immortalized by stable expression of the catalytic subunit 
of telomerase (Kiyono et al., 1998), and 293FT cells were maintained in DMEM (high 
glucose) supplemented with 10% FBS, 0.1 mM non-essential amino acid (GIBCO, Grand 
Island, NY, USA), 100 units/ml penicillin, 1 μg/ml streptomycin, 29.2 μg/ml L-glutamine 
and 100 μg/ml G418 (Promega, Madison, WI, USA) at 37°C under 5% CO2.  
Antibodies 
A mouse anti-human lamin A/C monoclonal antibody was purchased from Santa Cruz. A 
rat anti-HA monoclonal antibody (clone 3F10) was purchased from Roche (Mannheim, 
Germany), and a mouse anti-FLAG monoclonal antibody (clone M2) was obtained from 
Sigma-Aldrich (St. Louis, MO, USA). Rabbit polyclonal anti-GFP antibody (632460) 
was purchased from Clontech (Mountain View, CA, USA). Rabbit polyclonal anti-histone 
H3K9me3 antibody (ab8898) was obtained from Abcam (Cambridge, MA, USA). Anti-
rat and anti-mouse immunoglobulin G (IgG) species-specific antibodies linked to 
horseradish peroxidase (HRP) (NA935 and NA9310, respectively) were obtained from 
GE Healthcare Biosciences (Fairfield, CT, USA). Anti-rat and anti-mouse species-
specific antibodies conjugated to Alexa Fluor 594 (A-11007 and A-11005) and Alexa 
Fluor 488 (A-11006 and A-11001) dyes from Life Technologies (Carlsbad, CA, USA). 
Anti-goat species-specific antibodies linked to Alexa Fluor 594 (A-21468) dye from Life 
Technologies. 
cDNA cloning 
cDNA for human lamin A and lamin B1 was amplified by PCR from a cDNA library 
prepared from HeLa cells. Base substitution mutations were introduced into the lamin A 
cDNA through site-specific mutagenesis employing the overlap extension method with 
combination of the appropriate oligonucleotides and confirmation by DNA sequencing. 
The primers used for cDNA amplification and mutagenesis were as follows; 
WT lamin A, Forward: 5ʹ- GGAGAATTCAGAGACCCCGTCCCAGCGGCG-3ʹ 
  Reverse: 5ʹ- GAAGGATCCTTACATGATGCTGCAGTTCTG-3ʹ 
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lamin B1, Forward: 5ʹ-CCGCTCGAGATGGCGACTGCGACCCCCGT-3ʹ 
   Reverse: 5ʹ-GTGCGGCCGCTTACATAATTGCACAGCTTC-3ʹ 
K201R lamin A, Forward: 5ʹ-CAGACCATGAGGGAGGAACTGGACTT-3ʹ 
 Reverse: 5ʹ-CAGTTCCTCCCTCATGGTCTGCAGCC-3ʹ 
E203G lamin A, Forward: 5ʹ-ATGAAGGAGGGACTGGACTTCCAGAA-3ʹ 
 Reverse: 5ʹ-GAAGTCCAGTCCCTCCTTCATGGTCT-3ʹ. 
Plasmids 
Expression plasmids for FLAG-tagged WT, K201R, and E203G lamin A were generated 
by inserting lamin A cDNA between EcoRI and BamHI restriction sites of the pCSII-
hMTIIA(ΔGRE)-FLAG-IRES2-Venus lentivirus vector containing the human 
metallothionein-IIA promoter (Fumoto et al., 2007) or pCSII-EF-HA-MCS-IRES2-Venus 
lentivirus vector containing the human EF1α promoter. To construct CSII-
hMTIIA(ΔGRE)-HA-lamin B1-IRES2-Venus for transient expression or lentivirus 
production, the lamin B1 cDNA was inserted between the XhoI and NotI sites of the CSII-
hMTIIA(ΔGRE)-HA-MCS-IRES2-Venus lentivirus vector. Expression plasmids for 
CFP-SUMO2 and CFP-Ubc9 were described previously (Yamashita et al., 2004). Myc-
SUMO2 expression plasmid was created by inserting cDNA encoding SUMO2 into 
pCMV5-myc plasmid. 
Expression and purification of recombinant lamin A 
cDNA encoding full-length WT or mutant human lamin A (amino acids 1–646) was 
inserted into a pET47b vector (Merck Millipore, Frankfurter Straße, Darmstadt, 
Germany); the cDNA was extended at the N-terminus using a 6×His tag followed by a 
HRV 3C protease cleavage site. The protein was expressed in Escherichia coli BL21 
Codon Plus cells, which were the harvested by centrifugation. The expressed lamin was 
extracted from the cells with gentle shaking in an extraction buffer containing 8 M urea, 
100 mM NaH2PO4 (pH 8.0), and 10 mM Tris-HCl (pH 8.0) at room temperature for 4 h. 
After centrifugation at 100,000 × g for 30 min at room temperature, the supernatant was 
mixed with Ni–NTA sepharose (Qiagen, Valencia, CA). After extensive washing of the 
resin with an extraction buffer at pH 7.0, the bound protein was eluted using an extraction 
buffer at pH 4.5. The eluate was dialyzed with buffer A containing 500 mM NaCl, 20 mM 
Tris-HCl (pH 8.0), and 1 mM DTT for 3 h, and the polyhistidine tag was removed using 
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HRV 3C protease (Merck Millipore) by overnight digestion at room temperature. 
Complete digestion and absence of non-specific cleavage were confirmed by SDS-PAGE. 
Samples were concentrated using Amicon Ultra 50k NMWL centrifugal filters (Merck 
Millipore) and subjected to Superdex 200 size exclusion chromatography (GE 
Healthcare) with buffer A. The peak fraction was used for electron microscopy analysis. 
Paracrystal formation and EM 
Purified lamin A at 1 mg/ml in buffer A was mixed with nine volumes of double-distilled 
water at room temperature. After 15 min of incubation, aliquots were absorbed onto glow-
discharged carbon-coated copper grids, negatively stained with 2% uranyl acetate, and 
observed using a JEM1230 (JEOL) transmission electron microscope at an acceleration 
voltage of 100 kV. 
Preparation and transduction of recombinant lentiviruses 
Recombinant lentiviruses were produced as described previously (Yamashita et al., 2007). 
Briefly, 7 μg of the pCSII-hMTIIA(ΔGRE)-HA-IRES2-Venus plasmid containing cDNA 
for lamin A, 5 μg of pCAG-HIVgp, and 4 μg of pCMV-VSV-G-RSV-Rev were 
cotransfected into 293FT cells (3 × 106 cells/10-cm dish) using Lipofectamine 2000 
reagent (Life Technologies). At 48 h after DNA transfection, the medium containing the 
recombinant lentiviruses was passed through a 0.45-µm filter and was used for viral 
transduction experiments. HFF cells and HeLa cells were transduced with lentivirus by 
adding an appropriate volume of virus-containing medium with polybrene at a final 
concentration of 6 μg/ml for 6 h and washed with fresh medium three times. Cells stably 
expressing WT or mutant lamin A were cloned using the limiting dilution method. Virus 
transduction efficiencies were determined by counting GFP or Venus fluorescence-
positive cells using an IX-70 fluorescence microscope (Olympus, Tokyo, Japan). 
DNA transfection 
For transient expression experiments, plasmid DNA transfection was conducted by the 
calcium phosphate method as described previously (Yamashita et al., 2004). Expression 
plasmids (3 μg in total) were added to 1 × 105 HeLa cells in 12-well plates. The medium 
was changed at 4 h after transfection, and the cells were cultured in fresh medium. In the 
case of 293FT cells, DNA transfection was performed using Lipofectamine 2000 (Life 
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Technologies) according to the manufacturer instructions. Cells were used for 
biochemical analysis and immunostaining at 48 h after DNA transfection. 
Immunoprecipitation and Western blotting 
Cells were washed with phosphate-buffered saline (PBS) and lysed in lysis buffer 
containing 20 mM HEPES (pH 7.4), 150 mM NaCl, 0.5% NP-40, 1 mM DTT, 0.1 mM 
EDTA, 20 mM N-ethylmaleimide (NEM), 1 mM Na3VO4, 5 mM NaF, 1 mM sodium 
pyrophosphate, and protease inhibitor cocktail (Roche) for 5 min on ice. The lysates were 
subjected to sonication (SHARP UT-106H) at 4°C and centrifugation at 15,000 × g for 20 
min at 4°C. The supernatant was transferred to a new tube, and an anti-HA antibody 
(Roche) was added at a final concentration of 0.5 μg/ml. After incubation for 10 min at 
4°C, a mixture of Dynabeads conjugated with protein G and Dynabeads conjugated with 
protein A (Life Technologies) (1/1, v/v) was added to the supernatant, and the tubes were 
rotated for 3 h at 4°C. The beads were washed with lysis buffer supplemented with 100 
mM KCl five times and boiled in Laemmli sample buffer for 5 min. After brief 
centrifugation, the supernatants were subjected to SDS-PAGE and transferred to 
Immobilon-P membranes (Merck Millipore). Blots were incubated with the indicated 
primary antibodies in Tris-buffered saline (TBS) containing 5% skim milk and 0.05% 
Tween 20 and then with appropriate secondary antibodies conjugated with HRP. Bands 
were detected using an ECL kit (Thermo Scientific, Waltham, MA, USA). To quantify 
the relative amounts of endogenous and exogenous lamin A in HeLa and HFF cell lines, 
cells were harvested using cell scrapers, washed twice with ice-cold PBS, and lysed in 
CSK buffer (10 mM PIPES pH 6.8, 100 mM NaCl, 300 mM sucrose, 1 mM MgCl2, and 
1 mM EGTA) containing 0.1% Triton X-100. Equal amounts of protein were separated 
by SDS-PAGE and blotted onto Immobilon-P membranes. Both endogenous lamin A and 
HA-lamin A were detected using an anti-human lamin A/C antibody, and ECL signals 
were quantified using ImageJ. Protein concentrations were quantified using a protein 
assay kit (Bio-Rad, Hercules, CA, USA). 
Immunofluorescence and fluorescence microscopy 
Cells grown on glass coverslips were washed with PBS, fixed with 2% paraformaldehyde 
in PBS for 20 min, permeabilized in PBS containing 0.3% Triton X-100 for 15 min, and 
then blocked with 2% bovine serum albumin (BSA) in PBS. The coverslips were 
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incubated with the primary antibodies in TBS containing 0.1% BSA and 0.05% Tween 
20 overnight at 4°C. After three washes with TBS containing 0.05% Tween 20, the 
coverslips were incubated with Alexa Fluor 488- or 594-conjugated secondary antibodies 
in TBS containing 0.1% BSA and 0.05% Tween 20 for 1 h at 4°C. For F-actin staining, 
Alexa Fluor 594-conjugated phalloidin (Life Technologies) was used according to the 
manufacturer instructions. DNA was stained using Hoechst 33258 dye. After two washes 
with PBS, the coverslip was mounted onto a glass slide spotted with ProLong Gold and 
SlowFade Gold Antifade Reagents (Life Technologies). The fluorescence was then 
visualized by confocal laser scanning immunofluorescence microscopy (LSM510 Zeiss) 
or fluorescence microscopy (Zeiss AX10). The fluorescence intensities of the images 
were quantified using ImageJ software. 
BrdU labeling and detection 
Labeling of proliferating cells with 5-bromo-2'-deoxyuridine (BrdU) was performed 
using the BrdU labeling and detection kit II (Roche) according to a partial modification 
of the manufacturer instructions. Briefly, cells were cultured in media containing 10 µM 
BrdU for 24 h and fixed with 70% ethanol/15 mM glycine (pH 2.0) for 20 min at -30°C. 
The coverslips were then covered with mouse anti-BrdU antibody (clone BMG 6H8) and 
nucleases for 30 min at 37°C. After three washes with PBS, the coverslips were incubated 
with Alexa Fluor 594-conjugated goat anti-mouse IgG species-specific antibody for 1 h 
at room temperature. After three washes with PBS, the coverslips were incubated with 
Alexa Fluor 594-conjugated chicken anti-goat IgG species-specific antibody at room 
temperature for 1 h. After three washes with PBS, the coverslips were incubated with rat 
anti-HA antibody (clone 3F10) overnight at 4°C. After three washes with PBS, the 
coverslips were incubated with AlexaFluor 488-conjugated goat anti-rat IgG species-
specific antibody for 1 h at room temperature. The DNA was stained using Hoechst 33258 
dye. After two washes with PBS, the coverslip was mounted onto a slide spotted with 
ProLong Gold and SlowFade Gold Antifade Reagents. 
Lipid droplets staining and quantification of triacylglycerol 
Cells were cultured with media containing 200 μM oleic acid complexed to 0.22% fatty 
acid-free bovine serum albumin (BSA; Sigma) for 24 h. The lipid droplets were stained 
with 0.1 mM BODIPY 493/503 dye (Life Technologies). Lipid extraction was performed 
12 
 
according to a standard procedure (Bligh & Dyer, 1959). TAG content was measured 
using the triglyceride E-test (WAKO). Protein concentration was estimated using a 
protein assay kit (Bio-Rad); BSA was used as a standard. 
Trypan blue staining cell viability analysis 
Cells were trypsinized and collected by centrifugation at 100 × g for 10 min at 4°C. The 
cells were then suspended in PBS and an equal volume of 0.4% Trypan blue/PBS solution 
was added. The cell suspension was loaded into the counting chamber of a 
hemocytometer and the number of stained cells and total number of cells were 
immediately counted under the microscope. The percentage of stained cells was 
calculated by counting cells in five independent visual fields. Each field contained 
between 15 and 80 cells. 
Senescence-associated β-galactosidase (SA β-Gal) assay 
Cells were cultured on coverslips and fixed in PBS containing 2% formaldehyde and 
0.2% glutaraldehyde for 20 min at room temperature, followed by three washes in PBS. 
Cells were immersed in freshly prepared SA β-gal staining solution containing 1 mg/mL 
5-bromo-4-chloro-3-indolyl-β-D-galactoside in dimethylformamide, 30 mM citric 
acid/sodium phosphate buffer (pH 6.0), 5 mM potassium ferrocyanide, 5 mM potassium 
ferricyanide, 150 mM NaCl, and 2 mM MgCl2 and incubated overnight at 37°C. The 
coverslips were washed three times with PBS and mounted on glass slides with Glycergel 
Mounting Medium (Dako, Glostrup, Denmark). 
Statistical analysis 
Statistical significance was determined using Student’s t test. p< 0.05 was considered to 
be statistically significant. 
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2-5. Results 
To investigate the effect of the K201R and E203G mutations on SUMOylation of the 
lamin A polypeptide, I performed an in vivo SUMOylation assay. HeLa cells were co-
transfected with hemagglutinin (HA)-lamin A expression plasmids together with cyan 
fluorescent protein (CFP)-SUMO2 and CFP-Ubc9 expression plasmids. Cell lysates were 
prepared and subjected to immunoblot analysis 48 h after DNA transfection (Fig. 1A). 
Anti-HA antibodies detected a signal of high molecular weight in addition to the signal 
corresponding to the 75-kDa HA-tagged WT (HA-WT) lamin A in the lysate of cells co-
expressing CFP-SUMO2 and CFP-Ubc9. Separation of the polypeptides in a 7.5% 
polyacrylamide gel revealed that the apparent molecular mass of this slow-migrating band 
was as 180 kDa. This 180 kDa signal was scarcely detected in the lysate from cells 
expressing the K201R lamin A and E203G mutant, suggesting that the 180 kDa band 
represented SUMOylated lamin A. To confirm this finding, I performed 
immunoprecipitation experiments (Fig. 1B). Cells transfected with expression plasmids 
for HA-lamin A, CFP-SUMO2, and CFP-Ubc9 were subjected to immunoprecipitation 
using an anti-HA antibody followed by immunoblotting with an anti-green fluorescent 
protein (GFP) antibody. The anti-GFP antibody detected the 180 kDa band, indicating 
that the 180 kDa polypeptide may correspond to SUMOylated HA-lamin A, as reported 
previously (Zhang & Sarge, 2008). The apparent molecular mass of SUMOylated lamin 
A was much higher than the estimated molecular mass of the HA-lamin A polypeptide 
with a single-molecule CFP-SUMO2 conjugation. Similar result was also obtained in vivo 
SUMOylation assay using myc-SUMO expression plasmid instead of CFP-SUMO 
plasmid (Fig. 1C). The apparent molecular mass of the slow-migrating HA-lamin A 
polypeptide detected in the extract from cells co-expressing myc-SUMO2 and CFP-Ubc9 
was estimated to be 145 kDa. This phenomenon was also observed in lamin A as reported 
by Zhang and Sarge (Zhang & Sarge, 2008) and in other SUMOylation substrates 
(Hietakangas et al., 2003; Kotaja et al., 2002; Sapetschnig et al., 2002; Subramanian et 
al., 2003).  
The intranuclear localization patterns of K201R and E203G are different 
Because SUMOylation has been shown to cause changes in the subcellular localization 
of target proteins (Gill, 2004), I investigated the effect of the K201R and  
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Figure 1.  Decrease in SUMOylation of lamin A by K201R and E203G mutation. 
(A) HeLa cells were transfected with plasmids expressing the indicated proteins and 
directly lysed in boiled Laemmli sample buffer. Polypeptides in whole cell lysates were 
separated in a 7.5 % SDS polyacrylamide gel and subjected to western blot analysis 
using anti-HA and anti-GFP antibodies. (B) HeLa cells were transfected with plasmids 
expressing the indicated proteins and lysed in lysis buffer containing N-ethylmaleimide 
(NEM). HA-lamin A was immunoprecipitated using an anti-HA antibody and then 
SUMOylated HA-lamin A polypeptides were detected by western blot analysis using 
anti-GFP antibodies. (C) 293FT cells were transfected with plasmids expressing the 
indicated proteins and directly lysed in boiled Laemmli sample buffer. Polypeptides in 
whole cell lysates were separated in a 10 % SDS polyacrylamide gel and subjected to 
western blot analysis using anti-HA antibodies. 
A 
B C 
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E203G mutations on lamin A distribution. Two types of expression drivers, the human 
metallothionein IIA (hMT-IIA[ΔGRE]) promoter and the human elongation factor-1 
alpha (EF1 gene promoter, were adopted for low-level (Fumoto et al., 2007) and high-
level expression (Nelson et al., 2010; Ye et al., 1998), respectively, because the 
overexpression of proteins occasionally results in aggregates or causes mislocalization of 
proteins. HeLa cells were simultaneously transfected with WT, K201R, or E203G HA-
lamin A expression plasmids and CFP-Ubc9 with or without the CFP-SUMO2 plasmid. 
Immunoblot analysis with an anti-lamin A/C antibody revealed that the amount of 
exogenous HA-lamin A expressed by the hMT-IIA(ΔGRE) promoter and that expressed 
by the EF1α promoter were approximately 1.6- and 3.4-fold higher than the amount of 
endogenous lamin A, respectively (Fig. 2A), and slower migrating signals were not 
detected under this condition. I assume that failure in detecting the slower migrating 
signals using anti-lamin A/C monoclonal antibody was due to its low binding affinity to 
the antigen because anti-HA antibody certainly visualized the slower migrating signals as 
shown in Fig. 1A. The subcellular localization of HA-lamin A expressed by the hMT-
IIA(ΔGRE) and EF1α promoters, determined using an anti-HA antibody, is shown in Fig. 
2B and Fig. 2C, respectively. WT and K201R lamin A were normally localized at the 
nuclear periphery regardless of the promoter used. In contrast, the distribution pattern of 
E203G lamin A unexpectedly depended on the promoter type. E203G lamin A expressed 
by the hMT-IIA(ΔGRE) promoter was widely distributed inside the nuclei in addition to 
at the nuclear periphery, whereas many small aggregates were observed along the nuclear 
membrane when E203G lamin A was expressed by the EF1 promoter (Fig. 2C), as 
described in previous reports (Lloyd et al., 2002; Zhang & Sarge, 2008). Considering that 
the cytomegalovirus major immediate-early promoter/enhancer, a commonly used strong 
driver, was used in both previous studies, I speculate that accumulation of E203G lamin 
A beyond a certain threshold limit may have resulted in the formation of aggregates in 
the nuclei. Therefore, I decided to use the vector carrying MT-IIA(ΔGRE) to express 
lamin A in all subsequent experiments. Unexpectedly, the distribution patterns of WT, 
K201R, and E203G lamin A did not appear to change upon co-expression with CFP-
SUMO2, suggesting that SUMOylation of lamin A is not involved in the regulation of the 
subcellular localization of lamin A. 
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Figure 2.  Different localization of WT, K201R and E203G lamin A. (A) HeLa cells 
were transfected with expression plasmids as indicated, and directly lysed in boiled 
Laemmli sample buffer. HA-lamin A polypeptides were detected by western blotting 
analysis using anti-HA antibody. HA-lamin A was expressed under the control of the 
hMTIIA(ΔGRE) promoter (lanes 2-7) and EF1α promote (lanes 8-13). (B and C) HeLa 
cells were transfected with plasmids expressing HA-lamin A, CFP-SUMO2 and CFP-
Ubc9 and stained with an anti HA-antibody. HA-lamin A signals were visualized by 
confocal fluorescence microscopy. Expression of HA-lamin A was driven by 
hMTIIA(ΔGRE) promoter (B) or EF1α promoter (C). Bar, 5 µm. 
A 
B 
C 
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K201R and E203G lamin A formed paracrystals in in vitro studies 
Lamin A belongs to the type V intermediate filament family and assembles into higher 
order structures in vivo and in vitro (Stuurman et al., 1998). Because the E203G mutation 
lies between the two α-helical rod domains that are involved in coiled-coil dimer 
formation, I speculate that the E203G mutation destroys or weakens the homodimer 
formation ability of lamin A. To examine this possibility, I obtained recombinant WT and 
mutant lamin A, and then compared their ability to form paracrystals. In this study, I 
expressed the mature form (646 amino acids) of both WT and mutant lamin A in bacteria 
(Weber et al., 1989), purified them to homogeneity, and used the purified lamins to 
investigate paracrystal formation under conditions of reduced salt concentrations 
(Stuurman et al., 1998). The resultant paracrystals were negatively stained with uranyl 
acetate and then detected by transmission electron microscopy (Fig. 3). The sizes and 
shapes of the paracrystals and their typical stripe patterns did not differ between the three 
constructs. 
E203G lamin A interferes with the normal distribution of WT lamin A in a 
dominant-negative manner 
Both the K201R and E203G mutants apparently formed paracrystals in vitro. Next, I 
evaluated whether these mutants could interact between themselves and/or with WT 
lamin A in vivo. To test the interaction between WT and mutant lamin A, HA-tagged and 
FLAG-tagged lamin A (WT, K201R, and E203G) were simultaneously expressed in HeLa 
cells, and the association between HA- and FLAG-lamin A were examined by 
immunoprecipitation using an anti-HA antibody followed by immunoblotting using an 
anti-HA or anti-FLAG antibody. As shown in Fig. 4A, both K201R and E203G were 
associated with WT-lamin A. In addition, there was no substantial difference among 
binding affinities between WT-WT, WT-mutant, and mutant-mutant interactions 
regardless of the absence or presence of CFP-SUMO2. SUMOylated lamin A was not 
detected in immunoprecipitates, presumably due to its low amount or deSUMOylation 
during sample preparation. This result suggests that the E203G and K201R lamin A 
mutants associate with WT lamin A and between themselves in vivo. 
   The association of E203G lamin A with WT lamin A raises the possibility that 
expression of E203G lamin A may impair the normal localization of WT lamin A. To test  
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Figure 3.  Structural analysis of paracrystals assembled from purified WT, 
K201R, and E203G lamin A proteins. Bacterially expressed and purified WT, K201R 
and E203G lamin A proteins were allowed to self-assemble into paracrystals in vitro, 
were negatively stained, and were analyzed by transmission electron microscopy. 
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Figure 4.  Dominant-negative inhibition of localization by E203G lamin A. (A) 
293FT cells were transfected with plasmids expressing the indicated proteins and lysed 
in lysis buffer containing 20 mM NEM. HA-lamin A was immunoprecipitated using an 
anti-HA antibody. HA- and FLAG-lamin A polypeptides were detected by western 
blotting analysis using anti-HA and anti-FLAG antibodies, respectively. Relative 
amounts of immunoprecipitated HA-lamin A and co-immunoprecipitated FLAG lamin 
A were determined by quantifing the signals using ImageJ. Binding affinity between HA- 
and FLAG-lamin A was defined as a ratio of FLAG-lamin A/ HA-lamin A. Binding 
affinities between the combinations of lamin A indicated were shown as values relative 
to that of WT-WT in the table. (B) HeLa cells were transfected with plasmids expressing 
HA-lamin A, FLAG-lamin A, CFP-SUMO2 and CFP-Ubc9. HA-lamin A (green) and 
FLAG-lamin A (red) were immunostained and visualized by confocal fluorescence 
microscopy. Bar, 5 µm. 
A 
B 
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this hypothesis, HeLa cells were co-transfected with FLAG-tagged and HA-tagged WT, 
K201R, and E203G lamin A, and the distribution of lamin A was determined by 
immunostaining (Fig. 4B). A large portion of WT lamin A was abnormally localized 
inside the nuclei together with E203G lamin A, indicating that E203G lamin A may 
interfere with the normal localization of WT lamin A in a dominant-negative manner. 
E203G mutant lamin A does not affect the normal localization of lamin B1 
Interaction between lamin A and lamin B1 has been demonstrated by yeast two-hybrid 
(Ye & Worman, 1995) and fluorescence resonance energy transfer experiments. Many 
studies have shown that a set of LMNA mutations in association with progerin impaired 
the normal distribution of lamin B1 (Delbarre et al., 2006). Therefore, 
immunoprecipitation experiments were conducted to examine the interaction between 
E203G and K201 R lamin A and lamin B1. As shown in Fig. 5A, the K201R and E203G 
lamin A mutants, and WT lamin A co-immunoprecipitated with lamin B1 regardless of 
whether CFP-SUMO2 was simultaneously expressed. I then examined the effects of 
K201R and E203G lamin A on the subcellular localization of lamin B1. The results 
revealed that low-level and transient expression of K201R and E203G did not affect the 
normal localization of lamin B1, as shown in Fig. 5B.  
Transient expression of E203G lamin A impairs peripheral heterochromatin 
formation 
Several lines of evidence suggest that lamin A is involved in the formation of 
heterochromatin, especially at the nuclear periphery (Shumaker et al., 2006; Solovei et 
al., 2013). To examine the effect of the expression of K201R and E203G lamin A on 
heterochromatin formation, heterochromatin in HeLa cells expressing E203G lamin A 
was visualized using an antibody targeting the trimethylation at the lysine 9 (K9) residue 
of histone H3 (H3K9me3; Fig. 6A). Peripheral heterochromatin was observed in control 
HeLa cells and in HeLa cells overexpressing WT or K201R lamin A (Fig. 6A, B). In 
contrast, cells expressing E203G lamin A exhibited a loss of H3K9me3 fluorescence at 
the nuclear periphery (Fig. 6A, B). Quantification of the H3K9me3 signals showed a 
statistically significant reduction of heterochromatin signals at the nuclear periphery in 
E203G-expressing cells (Fig. 6C), indicating that E203G lamin A may have lost the 
activity responsible for peripheral heterochromatin formation. 
21 
 
  
A 
B 
Figure 5.  Effect of E203G lamin A expression on localization of lamin B1. (A) 
293FT cells were transfected with plasmids expressing the indicated proteins. HA-
lamin B1 was immunoprecipitated using an anti-HA antibody. HA-lamin B1 and 
FLAG-lamin A (WT, K201R or E203G) were detected by western blotting analysis 
using anti-HA and anti-FLAG antibodies, respectively. (B) HeLa cells were transfected 
with plasmids expressing HA-lamin B1, FLAG-lamin A (WT, K201R or E203G), CFP-
SUMO2 and CFP-Ubc9. HA-lamin B1 (green) and FLAG-lamin A (red) were 
visualized by confocal microscopy. Bar, 5 µm. 
22 
 
 
A 
B 
C 
Figure 6.  Expression of E203G lamin A decreases peripheral heterochromatin. 
(A) HeLa cells were transfected with plasmids expressing HA-lamin A (WT, K201R or 
E203G), CFP-SUMO2 and CFP-Ubc9. At 48 h after transfection, cells were stained 
using anti-HA (red) and anti-H3K9me3 (green) antibodies. Bar, 5 µm. (B) HA and 
H3K9me3 fluorescence signals on images in Fig.5A were quantified using ImageJ 
software and are shown as a 3D graph. The z-axis indicates the intensity of fluorescence. 
Black and red lines indicate the intensity of green fluorescence (H3K9me3 signal) and 
red fluorescence (HA-lamin A) signal, respectively. (C) Quantitative analysis of cells 
forming peripheral heterochromatin (>45 cells were analyzed). Data are shown as means 
± SEM. (***, p < 0.0005 vs. WT) and represent two separate experiments.  
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Multinucleated giant cells induced by long-term expression of E203G lamin A ceased 
to proliferate 
Given that cardiomyopathy induced by the E203G mutation takes decades to develop, I 
generated HeLa cell lines stably expressing lamin A and investigated their phenotypes 
over a long period. HeLa cells were transduced with a lentiviral vector harboring cDNA 
encoding WT, K201R, and E203G lamin A at a multiplicity of infection of approximately  
0.3, and cell lines were then established using the limiting dilution method. The cellular 
morphology of the obtained cell lines was observed by F-actin staining (Fig. 7A). The 
expression level of exogenous HA-lamin A in each cell line expressing WT, K201R, or 
E203G lamin A was similar to that of endogenous lamin A (Fig. 7C and Fig. 10A) and no 
slower migrating signal was detected using anti-lamin A/C antibody. Multinucleated cells 
and giant cells appeared in HeLa cell lines stably expressing E203G lamin A, but not in 
the control cell lines transduced with the empty vector or in cell lines stably expressing 
WT or K201R lamin A (Fig. 7D). As shown in the lower panel of Fig. 7B, bridge-like 
structures connecting two nuclei were often observed. Trypan blue exclusion revealed 
decreased viability in the cell line expressing E203G lamin A (Fig. 7E). To determine 
when multinucleated or giant cells emerge, cellular morphology was monitored over 1 
month after the lentivirus expressing E203G lamin A was transduced into HeLa cells (Fig. 
7F). The number of cells exhibiting abnormal morphology did not significantly increase 
in the first couple of days. However, the population of aberrant morphological cells 
gradually increased 1 week after virus transduction and reached a maximum 
(approximately 6%) level after 1 month. 
   To determine whether the multinucleated cells proliferated, 5-bromo-2'-deoxyuridine 
(BrdU) was added to the cells 21 days after virus transduction, and BrdU-incorporating 
cells were detected using an anti-BrdU antibody. Under these conditions, 93.7% of the 
HA-E203G lamin A-negative cells were labeled with BrdU. In contrast, 12.2% of the 
multinucleated giant cells and 51.5% of the cells with normal morphology expressing 
HA-E203G lamin A incorporated BrdU (Fig. 7G). It should be noted that the BrdU signal 
was significantly reduced in HeLa cells with HA-lamin A signals. These results indicate 
that overexpression of E203G lamin A reduced cell proliferation and that the 
multinucleated giant cells ceased to proliferate.  
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Figure 7.  Multinucleated giant cells emerge after long-term expression of E203G 
lamin A. (A and B) (A) HeLa cell lines obtained by transduction of lentiviruses carrying 
empty vector (Vec) or expressing HA-WT, K201R or E203G were stained with anti-HA 
antibody (green) and Alexa Fluor 594-phallidin and visualized by a fluorescence 
microscopy at low magnification (100×). (B) Images at high (400×) magnification. 
Upper panel, control HeLa cell line transduced with an empty virus; middle and lower 
panels, HeLa cell line expressing E203G lamin A. Bar, 50 μm.  
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Figure 7.  Multinucleated giant cells emerge after long-term expression of E203G 
lamin A. (C) The amount of endogenous and HA-lamin A expressed in each cell line at 
approximately 1 month after virus transduction used in Fig. 7A, B, D, and E was 
determined by western blotting analysis using an anti-lamin A/C antibody. Equal 
amounts of protein were loaded in each lane. Approximately 100 kDa signals were non-
specific bands. (D) The percentage of multinucleated or giant cells in cell lines 
transduced by lentiviruses carrying an empty vector (Vec) or expressing HA-WT, 
K201R, or E203G lamin A was calculated. Data are shown as the mean ± SEM. (**, p < 
0.005 vs. Vec). More than 500 cells were scored in three independent images. (E) The 
rate of cell death in cell lines transduced by lentivirus carrying empty vector (Vec) or 
expressing WT, K201R, or E203G was calculated by Trypan blue exclusion assay. Data 
are shown as the mean ± SEM. (**, p < 0.005 vs. Vec) More than 150 cells were scored 
in eight independent images. (F) Multinucleated or giant cells in the HeLa cell population 
transduced by lentiviruses expressing E203G lamin A were counted from day 2 to day 
28. More than 4000 cells were scored in three independent images. (G) HeLa cells were 
transduced with lentiviruses expressing E203G lamin A. At 20 days after viral 
transduction, cells were cultured in media containing 10 µM BrdU for 24 h, then fixed 
and immunostained with an anti-BrdU antibody. Cells expressing E203G lamin A were 
detected by their GFP signal. A multinucleated cell is indicated by the arrowhead. Bar, 
10 µm. 
C 
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Long-term expression of E203G lamin A induces aberrant lipid accumulation 
An additional phenotype that I observed in HeLa cell lines stably expressing E203G lamin 
A was the accumulation of lipid droplets (LDs; Fig. 8A and B). To compare size and 
number of LDs in each cell line, cells were incubated in the absence or presence of oleic 
acid and LDs were visualized with the 4,4-Difluoro-1,3,5,7,8-Pentamethyl-4-Bora-3a, 
4a-Diaza-s-Indacene (BODIPY) dye. In the absence of oleic acid, the diameter of LDs 
observed in cells stably expressing E203G were approximately two times larger than that 
in cells carrying an empty vector (Vec) and cells stably expressing WT or K201R. When 
oleic acid was added to the medium, LDs in cell lines stably expressing E203G were 
larger than those in other cell lines. I next quantified triacylglycerol (TAG), the major 
component of LDs. Because the TAG content of cells could not be quantified with high 
confidence without the addition of oleic acid, the cells were incubated with oleic acid 
before their TAG content was quantified. The TAG content of the cell line stably 
expressing E203G was significantly higher than that of the Vec cell line. Conversely, the 
TAG contents of cell lines stably expressing WT or K201R lamin A tended to be 
significantly lower than that of the Vec cell line (Fig. 8C).  
Long-term expression of E203G lamin A induces premature senescence 
The large and flattened cells that appeared upon stable expression of E203G lamin A were 
morphologically similar to senescent cells. I next examined whether these cells develop 
premature senescence as a consequence of long-term expression of E203G lamin A. HeLa 
cells carrying human papilloma viruses E6 and E7 are not appropriate for evaluating 
cellular senescence (Hall & Alexander, 2003). Therefore, I transduced lentivirus 
expressing lamin A (WT, K201R, or E203G) into human normal foreskin fibroblasts 
(HFF) and cloned several HFF lines stably expressing HA-lamin A (Fig. 10B). The 
obtained cell lines were subjected to senescence-associated β-galactosidase (SA β-gal) 
staining within 1 month after virus transduction. As shown in Fig. 9, SA β-gal positive 
cells comprised 26% and 14% of the population expressing E203G lamin A but 2% or 
1% of the cells expressing WT, and 1% or 3% of K201R lamin A, respectively. Moreover, 
the expression levels of p53 and p16, which are typical senescence markers, were 
increased in multinucleated cells stably expressing E203G lamin A (Fig. 9C). These 
results clearly show that the expression of E203G lamin A causes cellular senescence via 
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the p53 and/or p16INK4a pathways. 
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Figure 8.  Aberrant lipid accumulation is caused by long-term expression of 
E203G lamin A. (A) HeLa cells were cultured in the absence or presence of 200 μM 
oleic acid for 24h and then HeLa cells fixed and DNA and lipid droplets (LDs) were 
stained with Hoechst 33258 dye (blue) and bodipy (green), respectively. Bar, 10 μm. (B) 
Diameter of 160 LDs in each cell line was measured using Image J and their size 
distribution and number were shown. (C) Triglyceride contents of each cell lines treated 
with 200 μM oleic acid. Data are shown as means ± SEM. (*, p < 0.05 vs. Vec). 
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Figure 9.  Induction of cellular senescence by long-term expression of E203G 
lamin A. (A) Immortal HFF cell lines expressing WT, K201R, or E203G lamin A were 
subjected to SA β-galactosidase staining. Bar, 50 μm. (B) Quantitative analysis of SA β-
Gal-positive cells. Approximately 400–800 cells were scored in eight independent 
images. Each bar represents data obtained with independent cell lines stably expressing 
HA-lamin A (WT, K201R, or E203G). Data are shown as means ± SEM. (***, p < 0.0005 
vs. WT). (C) Immortal HFF cells were transduced with lentiviruses expressing HA-
E203G lamin A. Eleven days after virus transduction, cells were fixed and 
immunostained with anti-HA antibody (red) and anti-p16INK4a or anti-p53 antibody 
(green). Typical multinucleated giant cell expressing HA-E203G lamin A is indicated by 
the dotted square. Bar, 100 µm. 
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Figure 10.  Expression level of HA-lamin A in established cell lines. Expression 
amounts of HA-lamin A (WT, K201R or E203G) in cell lines established by lentivirus 
transduction and limiting dilution cloning method were analyzed by western blot using 
anti-lamin A/C antibody. (A) Parental HeLa cell and cell lines expressing HA-lamin A 
as indicated. (B) Parental HFF cell and cell lines expressing HA-lamin A as indicated. 
A 
B 
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2-6. Discussion 
In this study, I investigated two lamin A mutations, K201R and E203G, at amino acid 
residues corresponding to a SUMOylation consensus site. Although these mutations 
resulted in defective SUMOylation of the lamin A polypeptide, as described in a previous 
report, K201R and E203G had different properties. For example, a large portion of E203G 
lamin A was distributed inside the nuclei, whereas K201R lamin A exhibited normal 
localization. Expression of E203G lamin A diminished the amount of heterochromatin at 
the nuclear periphery. Assuming that SUMOylation at the K201 residue is important for 
normal localization and plays a role in heterochromatin formation, expression of the 
K201R and E203G mutants of lamin A should cause similar phenotypes. Therefore, the 
varying types of phenotypic disruption caused by the K201R and E203G mutations 
strongly suggests that loss of SUMOylation is a common feature of these two mutants but 
may not be a causative defect in cells expressing the E203G mutant. It should be noted 
that the E203G mutation has been detected in FDC patients, whereas the K201R mutation 
has not been identified in any laminopathy. These lines of evidence suggest that defective 
SUMOylation at the K201 position of lamin A is not the predominant cause of FDC. To 
evaluate the roles of lamin A SUMOylation, I am now screening novel lamin A mutants 
exhibiting enhanced SUMOylation at K201. I believe that a comparative analysis using a 
loss of SUMOylation mutant (K201R) and a gain of SUMOylation mutant will provide 
further insight into SUMOylation of lamin A. 
   Although the K201R and E203G mutations are located at the center of the N-terminal 
α-helical rod domain responsible for homodimer formation, an in vitro filament formation 
experiment showed that these mutant lamins retain their capacity for higher-order lamin 
interactions. I further demonstrated that the K201R and E203G polypeptides could 
interact with WT lamin in HeLa cells and that E203G lamin A expression clearly disturbs 
the normal localization of WT lamin A, indicating that E203G expression may interfere 
with the normal localization or function of WT lamin A in a dominant-negative manner. 
It is possible that this dominant-negative effect on WT lamin A is involved in the onset of 
cardiomyopathy induced by the E203G mutation. E203G lamin A did not affect the 
localization of lamin B1, although E203G lamin A has the capability to interact with lamin 
B1. Considering that lamin A and lamin B preferentially assemble into homopolymers 
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comprising either lamin A or lamin B (Delbarre et al., 2006), and that lamin B could be 
localized to the nuclear membrane by itself via farnesylation on a C-terminal CaaX motif 
(Dechat et al., 2010), it is conceivable that the E203G mutation does not impair normal 
lamin B distribution. 
   Lamin A plays an important role in chromatin organization (Nikolova et al., 2004; 
Shumaker et al., 2006; Sullivan et al., 1999). In this study, I found that the expression of 
E203G markedly reduced heterochromatin levels at the nuclear periphery. Because the 
transcription of many genes is regulated by epigenetic control, it is likely that E203G 
lamin A disrupts transcriptional regulation through a decline in peripheral 
heterochromatin levels. Further studies are necessary to elucidate the molecular 
mechanism of peripheral heterochromatin formation by lamin A. 
   I observed that lipid accumulation is induced by the long-term expression of the 
E203G lamin A mutant. Interestingly, fatty metamorphosis has been reported in a member 
of a family with FDC caused by the E203G mutation (Bharati et al., 1992; Fatkin et al., 
1999); however, the nature of the relationship between lipid accumulation and FDC is 
unknown. 
   The most striking difference that I observed was the induction of premature 
senescence. To the best of our knowledge, this is the first report demonstrating that a 
mutant lamin A associated with cardiomyopathy induces cellular senescence. Some 
laminopathies have a dominant inheritance pattern, suggesting that the expression levels 
of the mutant lamin A are nearly equal to those of WT lamin A. Therefore, I adopted a 
lentivirus carrying the hMTIIA(ΔGRE) promoter expression system to reproduce the 
appropriate expression balance between the mutant and WT lamin A, and I used this 
vector to successfully obtain cell lines exhibiting abnormal nuclear morphology and 
premature senescence. Expression of the typical senescence markers, p53 and p16INK4a, 
was increased in multinucleated cells stably expressing E203G lamin A. Although it is 
assumed that the p53 and p16INK4a-pRb pathways are involved in the premature 
senescence of fibroblasts derived from progeria and lipodystrophy patients (Caron et al., 
2007; Kudlow et al., 2008), to the best of my knowledge, this is the first study to 
demonstrate that mutant lamin A associated with FDC induces senescence via the p53 
and p16INK4a-pRb pathways. Although it remains unclear how E203G lamin A induces 
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cellular senescence, it is possible that the alteration of peripheral heterochromatin levels 
by E203G lamin A is involved in cellular senescence, as previously reported for progerin 
(Scaffidi & Misteli, 2005; Shumaker et al., 2006). 
   In summary, I provide evidence indicating that the expression levels and duration of 
expression of lamin A mutants are important for understanding the precise mechanisms 
linking lamin A mutations and abnormal events in nuclei. I believe that long-term 
expression of mutant lamin A is a simple and appropriate approach for cell biological 
research on late-onset laminopathies such as dilated cardiomyopathy and lipodystrophy. 
On the other hand, it is unclear why and how E203G mutant lamin A specifically causes 
dilated cardiomyopathy. To solve the problem, cardiomyocytes stably expressing E203G 
mutant lamin A should be established using the expression system used in this study. Cell 
lines established using available immortalized human cardiomyocytes (for example 
AC16) (Davidson et al., 2005) and/or ES cells as well as induced pluripotent stem cells 
(Takahashi & Yamanaka, 2006) might provide a model to understand the relationship 
between phenotypes and genotypes of laminopathies. 
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3. Functional analysis of lamin A SIM: Requirement of lamin A  
  SIM for lamin A reassembly at the end of mitosis 
  
3-1. Summary 
Modification of proteins with small ubiquitin-related modifier (SUMO; SUMOylation) is 
involved in the regulation of various biological processes. Recent studies have 
demonstrated that noncovalent associations between SUMOylated proteins and co-
operative proteins containing SUMO-interacting motifs (SIMs) are important for the 
spatiotemporal organization of many protein complexes. In this study, I demonstrate that 
interactions between lamin A, a major component of the nuclear lamina, and SUMO 
isoforms are dependent on one of the four SIMs (SIM3) resided in lamin A polypeptide 
in vitro. Live cell imaging and immunofluorescence staining showed that SIM3 is 
required for accumulation of lamin A on the chromosomes during telophase, and 
subsequent evaluation of a panel of deletion mutants determined that a 156-amino acid 
region spanning the carboxyl-terminal Ig-fold domain of lamin A is sufficient for this 
accumulation. Notably, mutation of SIM3 abrogated the dephosphorylation of mitosis-
specific phosphorylation at Ser-22 of lamin A, which normally occurs during telophase, 
and the subsequent nuclear lamina reorganization. Furthermore, expression of a 
conjugation-defective SUMO2 mutant, which was previously shown to inhibit 
endogenous SUMOylation in a dominant-negative manner, also impaired the 
accumulation of wild type lamin A on telophase chromosomes. These findings suggest 
that interactions between SIM3 of lamin A and a putative SUMO2-modified protein plays 
an important role in the reorganization of the nuclear lamina at the end of mitosis.  
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3-2. Abbreviations 
NPC, the nuclear pore complex; SIM, SUMO-interacting motif; BAF, barrier-to-
autointegration factor; AKAP149, A-kinase-anchoring protein 149; GST, glutathione S-
transferase; PP1, protein phosphatase 1; NLS, nuclear localization signal 
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3-3. Introduction 
The nuclear lamina is a fibrous structure located beneath the inner nuclear membrane that 
interacts with chromatin, the nuclear pore complex (NPC), and LEM (LAP2, emerin, 
MAN1)-domain proteins, which are integral proteins that localize to the inner membrane 
of the nuclear envelope, thereby contributing both to nuclear structural stability and to 
regulation of chromatin organization in higher eukaryotes (Andrés and González, 2009). 
The lamina is composed primarily of two types of lamins: A-type (lamin A/C) and B-type 
(lamin B1, B2) lamins. Lamin polypeptides have well-defined conserved domains, 
including an N-terminal head domain, a central α-helical rod domain, and a C-terminal 
tail domain (Parry et al., 1986), and both types of lamins are known to self-assemble into 
higher-order structures through multiple steps. First, the lamin polypeptides form a 
coiled-coil dimer through parallel association of two α-helical rod domains. Next, the 
lamin dimers associate in a head-to-tail fashion. Finally, intermediate filaments are 
formed by the interaction of these polymers in an antiparallel fashion (Dechat et al., 2010). 
During mammalian cell mitosis, the nuclear lamina, as well as the NPC and LEM-domain 
proteins, is disassembled and reassembled. Notably, however, both the timing of nuclear 
lamina disassembly and the pathways governing reassembly differ between A-type and 
B-type lamins (Georgatos et al., 1997; Moir et al., 2000). For instance, A-type lamins 
exhibit barrier-to-autointegration factor (BAF)-dependent localization to a specialized 
region of the telophase chromosome mass near the spindle, termed the “core” region, and 
organize the nuclear lamina while interacting with BAF and the LEM-domain protein 
emerin. In contrast, B-type lamins and NPC components accumulate at the non-core 
regions of telophase chromosomes (Haraguchi et al., 2008).  
   It is assumed that phosphorylation plays a key role in the regulation of lamin 
disassembly/assembly. Phosphorylation of lamins occurs at specific sites within the head 
and tail domains, and is mediated by mitotic kinases or cyclin-dependent kinase 1 (Cdk1) 
both in vivo and in vitro (Peter et al., 1990; Hocevar et al., 1993; Goss et al., 1994). 
Notably, the phosphorylation of lamin A at the beginning of mitosis acts as a trigger for 
nuclear envelope breakdown (Ward and Kirschner, 1990; Heald and McKeon, 1990). 
Meanwhile, dephosphorylation of lamins by protein phosphatase 1 (PP1) is required for 
nuclear lamina reassembly during telophase and early G1 (Thompson et al., 1997). Lamin 
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B has also been reported to be dephosphorylated by the PP1/A-kinase-anchoring protein 
149 (AKAP149) complex (Steen et al., 2000), and Steen and Collas (2001) demonstrated 
that inhibition of AKAP149 binding by PP1 results in abrogated assembly of B-type 
lamins. The location(s) at which A-type lamins are dephosphorylated during telophase, 
however, and the mechanism by which this process is regulated have yet to be elucidated. 
Recent studies demonstrated that post-translational modification of proteins with small 
ubiquitin-related modifier (SUMO; SUMOylation) plays essential roles in both mitotic 
progression and phosphorylation. Indeed, immunostaining and biochemical analyses of 
mitotic cells indicated that SUMO1 and SUMO2/3 are conjugated to distinct proteins 
during mitosis. While SUMO1-modified proteins localize to the mitotic spindle during 
early mitosis and to the spindle midzone during late mitosis, SUMO2/3-modified proteins 
localize to the centromeres and kinetochores during prophase and metaphase, and appear 
to coat the chromosome arms at the metaphase-anaphase transition (Zhang et al., 2008). 
In particular, modification with SUMO2/3 results in localization of topoisomerase II to 
centromeres, while SUMO2/3-modified Nuf2 and BubR1 were found to recruit CENP-E 
to kinetochores (Azuma et al., 2005; Agostinho et al., 2008; Zhang et al., 2008). However, 
the precise function of the SUMO2/3-modified proteins that coat the chromosomes 
remains unclear. 
   SUMOylation of proteins can mediate novel protein-protein interactions with other 
proteins containing SUMO-interacting motifs (SIMs). The SIM is a hydrophobic motif 
with a loose consensus sequence (V/L/I-X-V/L/I-V/L/I) that interacts non-covalently 
with the hydrophobic groove of SUMO (Song et al., 2004; Hecker et al., 2006; Minty et 
al., 2000) and is involved in protein complex formation and the spatiotemporal tethering 
of SUMOylated proteins to specific structures such as the PML (promyelocytic leukemia) 
nuclear body, kinetochores, and transcription machinery (Lin et al., 2006; Zhang et al., 
2008; Gómez-del Arco et al., 2005). Although a number of SUMOylated proteins have 
been identified, and various effects of SUMOylation on these proteins have been partially 
characterized, the significance of such SUMO-SIM interactions is largely unclear. 
In this study, I identified four potential SUMO-interacting motifs (SIMs) within the lamin 
A polypeptide and generated a panel of SIM-defective lamin A mutants to investigate the 
function of these motifs. Our findings demonstrate that a SIM located within the carboxyl-
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terminal Ig-fold domain of lamin A, referred to hereafter as SIM3, is required for the 
chromosomal accumulation of lamin A during telophase. Furthermore, I show that SIM3 
plays an integral role in the proper dephosphorylation of mitosis-specific phosphorylation 
of lamin A during telophase, and in subsequent nuclear lamina reorganization. I propose 
that the activity of this SIM during the later stages of mitosis may be mediated by a 
SUMO2-modified protein(s) that is associated with telophase chromosomes.
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3-4. Experimental procedures 
Plasmids 
The plasmids used for mammalian expression of HA-tagged WT and lamin A SIM 
mutants were generated by inserting the respective human lamin A cDNA molecules into 
the pCSII-hMTIIA(ΔGRE)-HA-IRES2-Venus lentivirus vector containing the human 
metallothionein-IIA promoter, as described previously (Moriuchi et al., 2014). 
Meanwhile, 6×His- and GFP-tagged lamin A WT and SIM mutants were generated by 
inserting lamin A coding sequences between the BamHI and EcoRI restriction sites of the 
pET47b vector (Merck Millipore), and between the EcoRI and BamHI restriction sites of 
the previously constructed CSII-MT-GFP vector (Hashimoto et al., 2012), respectively. 
Base substitution mutations were introduced into the lamin A cDNA via site-specific 
mutagenesis using the overlap extension method, and were confirmed by DNA 
sequencing. While the WT SUMO1 and SUMO2 constructs were generated as described 
previously (Yamashita et al., 2004), the lamin A SIM mutants, lamin A deletion mutants, 
SUMO2 (G93A) mutant were generated by PCR using the following primers: 
Lamin A SIM1(EE), Forward: 5´-GACCCGAGAGGAGGAGATTGACAATGGGA-3´ 
     Reverse: 5´-AATCTCCTCCTCTCGGGTCTCATGACGGC-3´ 
SIM2(EE), Forward: 5´-CCAGGAGGAAGAGGACATCAAGCTGGCCCT-3´ 
   Reverse: 5´-GATGTCCTCTTCCTCCTGGTACTCGTCCAG-3´ 
SIM3(EE), Forward: 5´-GCTGGGCAGGAGGAGACGATCTGGGCTGC-3´ 
   Reverse: 5´-CCA GATCGTCTCCTCCTGCCCAGCCTTCA-3´ 
SIM4(EE), Forward: 5´-TCAGTGACTGAGGAAGAGGACGACGAGGAT-3´ 
   Reverse: 5´-CGTCGTCCTCTTCCTCAGTCACTGAGCGCA-3´ 
1-383, Forward: 5ʹ-GGAGAATTCAGAGACCCCGTCCCAGCGGCG-3ʹ 
      Reverse: 5ʹ-GAGGATCCTCACTCGCCCTCCAAGAGCTTGCGGTA-3ʹ 
384-664, Forward: 5ʹ-CCAGAATTCGGAGGAGAGGCTACGCCTGT-3ʹ 
        Reverse: 5ʹ-GAAGGATCCTTACATGATGCTGCAGTTCTG-3ʹ 
417-664, Forward: 5ʹ-TTAGAATTCGAAAAAGCGCAAACTGGAGT-3ʹ 
        Reverse: 5ʹ-GAAGGATCCTTACATGATGCTGCAGTTCTG-3ʹ 
436-664, Forward: 5ʹ-TTAGAATTCGACTAGCGGGCGCGTGGCC-3ʹ 
        Reverse: 5ʹ-GAAGGATCCTTACATGATGCTGCAGTTCTG-3ʹ 
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384-572, Forward: 5ʹ-CCAGAATTCGGAGGAGAGGCTACGCCTGT-3ʹ 
        Reverse: 5ʹ-AATGGATCCTTAGCTGCTGCAGTGGGAGCCG-3ʹ 
384-544, Forward: 5ʹ-CCAGAATTCGGAGGAGAGGCTACGCCTGT-3ʹ 
        Reverse: 5ʹ- ATGGATCCTTACACCAGCTTGCGCATGGCCACTTC-3ʹ 
417-572, Forward: 5ʹ-TTAGAATTCGAAAAAGCGCAAACTGGAGT-3ʹ 
        Reverse: 5ʹ-AATGGATCCTTAGCTGCTGCAGTGGGAGCCG-3ʹ 
SUMO2 (G93A), Forward: 5´-GTAAGATCTATGCCGACGAAAAGCCCAAGG-3´ 
   Reverse: 5´-GTAGTCGACTCAGTAGACAGCTCCCGTCT-3´ 
Cell culture and DNA transfection 
HeLa cells were cultured in Ham’s F-12 medium containing 10% fetal bovine serum 
(FBS; Nichirei Bioscience) at 37°C under 5% CO2. 293FT cells were maintained in 
DMEM (high glucose) supplemented with 10% FBS, 0.1 mM non-essential amino acids 
(Gibco [Invitrogen]), 100 U/ml penicillin, 1 μg/ml streptomycin, 29.2 μg/ml L-glutamine, 
and 100 μg/ml G418 (Promega) at 37°C under 5% CO2. 
   Transfection of plasmid DNA into HeLa cells was performed using the calcium 
phosphate method for immunofluorescence and the Polyethylenimine “Max” (Mw 4,000) 
(Polysciences) method for synchronizing experiments. For the calcium phosphate method, 
1 × 105 cells were seeded in 12-well plates and cultured overnight. The following day, 
DNA/calcium phosphate precipitates containing 3 μg of the indicated expression 
plasmids were added to each well. After 4 h, the precipitates were removed, and cells 
were cultured for 24 h in the appropriate medium. For polyethylenimine (PEI) 
transfection, DNA/PEI complexes containing 4 μg of HA-lamin A (WT or SIM3[EE]) 
and 12 μg of PEI were added to cells cultured in 60-mm cell culture dishes. 
Antibodies 
The mouse anti-human lamin A/C monoclonal antibodies (clone 636; 1:2000 and 1:500 
dilution for Western blotting [WB] and Immunofluorescence staining [IF], respectively), 
the mouse anti-c-myc monoclonal antibodies (clone 9E10; 1:500 dilution) and the rabbit 
anti-cyclin B1 polyclonal antibodies (1:5000 dilution) were purchased from Santa Cruz 
Biotechnology, the rat anti-HA monoclonal antibodies (clone 3F10; 1:500 dilution) and 
the mouse anti-His monoclonal antibodies (clone His-2; 1:5000 dilution) were purchased 
from Roche, the mouse anti-FLAG monoclonal antibodies (clone M2; 1:5000 and 1:500 
45 
 
dilution for WB and IF, respectively) were obtained from Sigma-Aldrich. The rabbit anti- 
phospho-lamin A/C (Ser22) monoclonal antibodies (clone D2B2E; 1:2000 and 1:2500 
dilution for WB and IF, respectively) were purchased from Cell Signaling Technology. 
Meanwhile, horseradish peroxidase-conjugated secondary antibodies specific to rat, 
mouse, and rabbit immunoglobulin G (IgG; NA935, NA9310, and NA934V, respectively, 
1:7000 dilution) were obtained from GE Healthcare Life Sciences. Anti-rat and anti-
mouse species-specific antibodies conjugated to Alexa Fluor 594 (A-11007 and A-11005) 
and Alexa Fluor 488 (A-11006 and A-11001) were purchased from Life Technologies. 
All Alexa Fluor-conjugated antibodies were used at a 1:500 dilution. 
Western blotting 
PVDF membranes were blocked by incubation with 5% skim milk in Tris-buffered saline 
(TBS) for 30 minutes, and then probed by incubation with the indicated primary 
antibodies diluted in TBS containing 0.05% Tween-20 (TBST) and 5% skim milk at 4°C 
overnight, followed by the appropriate HRP-conjugated secondary antibodies suspended 
in TBST. Bands were detected using an enhanced chemiluminescence (ECL) western 
blotting detection kit (Thermo Scientific). 
Immunofluorescence and fluorescence microscopy 
Cells were grown on glass coverslips, washed with PBS, fixed by incubating in 2% 
paraformaldehyde in PBS for 20 min, permeabilized in PBS containing 0.3% Triton X-
100 for 15 min, and blocked with 2% BSA in PBS. The coverslips were then incubated 
overnight with the appropriate primary antibodies diluted in PBS containing 0.1% BSA 
at 4°C. After three washes with PBS, the coverslips were incubated for 1 h with Alexa 
Fluor 488- or Alexa Fluor 594-conjugated secondary antibodies in PBS containing 0.1% 
BSA at 4°C. DNA was stained with Hoechst 33258 dye (Calbiochem). After two washes 
with PBS, the coverslips were mounted on glass slides spotted with ProLong Gold and 
SlowFade Gold antifade reagents (Life Technologies).  
   For live cell imaging experiments, cells were grown in glass-bottom culture dishes 
(Iwaki), transfected with GFP(105)-fusion plasmids, and placed in a stage-top incubator 
(Tokai Hit) for approximately 22–30 h. GFP(105) is a GFP mutant that contains the 
S65T/F64L/V163A/S175G amino acid substitutions that exhibits enhanced fluorescence 
intensity (Yamasaki et al., 1998). The fluorescent immunocomplexes and GFP(105)-
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tagged proteins were imaged using an oil-immersion objective lens (PLAPO 63×/NA 1.4) 
and a Leica HyD detector mounted on a Leica TCS SP8 confocal laser scanning 
immunofluorescence microscope (Leica Microsystems). Image processing was 
performed using Adobe Photoshop software. 
Quantitative colocalization analysis of immunofluorescence confocal images 
The Fiji program was used to quantify the degree of colocalization between the two 
indicated fluorescence signals. Prophase, anaphase and telophase cells were selected, and 
the entire cellular region of each selected cell was examined. Pearson’s correlation 
coefficient was calculated using the Fiji plug-in colocalization threshold program. 
GST pull-down assay 
His-tagged recombinant WT lamin A and SIM mutants were expressed in Escherichia 
coli cells and extracted with lysis buffer (20 mM Tris-HCl [pH 8.0], 150 mM NaCl, 0.5% 
Triton X-100) containing 6 M urea. His-tagged lamin A proteins were then precipitated 
by incubation with glutathione-sepharose beads covered with GST-SUMO-1, -2, or -3 in 
lysis buffer containing 2 M urea. GST and GST-SUMO polypeptides were eluted from 
the beads in 5 mM reduced glutathione, separated by SDS-PAGE, and detected by 
immunoblotting using anti-His antibodies. GST and GST-SUMOs were also detected by 
Coomassie brilliant blue staining after separation by SDS-PAGE. 
Cell synchronization 
HeLa cells were synchronized in mitosis using thymidine, hydroxyurea, and nocodazole 
blocks. The cells were presynchronized in S phase by incubation with 2.0 mM thymidine 
for 20 h, transfected at 6 h after release from thymidine, and further incubated for 7 h at 
37°C. The cells were resynchronized at the G1/S transition by incubation with 1.5 mM 
hydroxyurea for 13 h. The G1/S cells were then washed, incubated in fresh medium for 
11 h, and synchronized at the early phase of mitosis by treatment with medium containing 
100 ng/ml nocodazole for 6 h. Mitotic cells were collected by the shake-off method, 
aliquoted, and cultured in fresh nocodazole-free medium for the indicated lengths of time. 
The cells were then immediately lysed in sample buffer.  
Statistical analysis 
Student’s t test was utilized to evaluate statistically significant differences between results. 
p < 0.05 was considered statistically significant.  
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3-5. Results 
Identification of a SIM that is necessary for the interaction of lamin A with SUMO 
in vitro 
Four regions matching the consensus SIM amino acid sequence were identified in lamin 
A using the GPS-SUMO (Zhao et al., 2014) with the low threshold (Fig. 1A). To evaluate 
the interaction between lamin A and SUMO, I first performed a GST pull-down assay 
using a recombinant 3×His tagged lamin A and the three GST-SUMO isoforms, 
respectively. While His-lamin A was pulled down by GST-SUMO1, -SUMO2, and -
SUMO3, but not by GST (Fig. 1B), the intensity of the lamin A bands from the GST-
SUMO2 and -SUMO3 pull-downs were notably greater than that from the GST-SUMO1 
pull-down sample. This result suggests that lamin A directly interacts with all isoforms of 
SUMO, but that the interactions between lamin A and SUMO2 and SUMO3 seem to be 
stronger than that with SUMO1 in vitro. To determine which of the four SIM consensus 
sequences is necessary for the interaction between lamin A and SUMO2 in vitro, I 
examined the SUMO-binding abilities of a series of SIM-defective lamin A mutants 
(SIM[EE]) that were generated by substituting two hydrophobic amino acids with 
glutamic acid residues within each respective SIM (Fig. 1C) (Lin et al., 2006). His-tagged 
WT lamin A, as well as His-tagged lamin A proteins carrying single, double, or triple EE 
mutations in SIM1, SIM2, and/or SIM4, were effectively pulled down by GST-SUMO2. 
Conversely, the His-lamin A protein carrying the SIM3(EE) mutation was not pulled 
down by GST-SUMO2. These results suggest that SIM3 is necessary and sufficient for 
the interaction between lamin A and SUMO2 in vitro. 
SIM3 is responsible for the association of lamin A with telophase chromosomes 
To examine the role of the four SIMs in the subcellular localization of lamin A, the HA- 
tagged WT lamin A and SIM(EE) mutants were transiently expressed in HeLa cells and 
visualized by immunofluorescence staining (Fig. 2A). At 24 h post-transfection, each of 
the four SIM(EE) mutants exhibited lamina localization patterns that were similar to that 
of the WT. Furthermore, there were no obvious differences in the signal intensities 
between the SIM(EE) mutants and WT lamin A. Surprisingly, however, at 48 h after 
transfection, the cells expressing SIM2(EE) and SIM3(EE) displayed abnormal nuclear 
laminas with small and spherical foci, respectively. These abnormalities emerged after   
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Fig. 1. Identification of SUMO-interacting motifs (SIMs) in lamin A. (A) 
Domain structure of the lamin A polypeptide. SIM(EE) mutants were generated 
by substitution of two hydrophobic amino acids with glutamic acid residues in 
each respective SIM. (B) Interaction between lamin A and small ubiquitin-related 
modifier 1 (SUMO1), 2, and 3. A lysate prepared from an Escherichia coli culture 
expressing His-lamin A was added to glutathione-sepharose beads that were 
preadsorbed with GST, GST-SUMO1, GST-SUMO2, or GST-SUMO3. After 
incubation and extensive washing, the proteins were eluted with 5 mM reduced 
glutathione and separated by sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE). His-lamin A was then detected by western blot 
analysis using an anti-His antibody. Meanwhile, GST and the GST-SUMO 
paralogs were visualized by Coomassie brilliant blue staining (CBB). The data is 
representative of two independent experiments with similar results.  
A 
B 
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Fig. 1. Identification of SUMO-interacting motifs (SIMs) in lamin A.  
(C) Analysis of interactions between SUMO2 and lamin A SIM(EE) mutants in 
vitro. Wild type (WT) lamin A and a series of His-lamin A mutant proteins were 
expressed in E. coli and subjected to GST pull-down analysis, as described in (B). 
His-lamin A proteins were pulled down using glutathione-sepharose beads 
preadsorbed with either GST or GST-SUMO2, and detected by western blot 
analysis with an anti-His antibody. The data is representative of two independent 
experiments with similar results. His-lamin A, GST, and GST-SUMO2 were 
visualized by Coomassie staining. 
C 
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cell division, raising the possibility that mutation of these SIMs might impair the 
disassembly or assembly of lamin A during mitosis. Therefore, to monitor the dynamics  
of lamin A during mitosis in living cells, I generated a panel of fluorescent lamin A 
reporters (Fig. 2B). Both SIM2(EE) and SIM3(EE) exhibited normal disassembly at the 
beginning of mitosis, and there were no significant differences in the localization patterns 
of the GFP-fused WT and SIM mutants between prophase and metaphase (data not 
shown). However, the two mutants exhibited abnormal localization at the later stage of 
mitosis. GFP-fused WT lamin A began to associate with the mitotic chromosomes at 7 
min after the metaphase-anaphase transition (indicated as time 0), where it accumulated 
at the core region, and the nuclear lamina was organized after at least 17 min, as 
previously reported (Haraguchi et al., 2008). Meanwhile, GFP-SIM2(EE) exhibited a 
fluorescence pattern similar to that of WT lamin A; however, small foci were observed 
after 17 min surrounding the daughter nuclei. Conversely, GFP-SIM3(EE) did not 
localize to mitotic chromosomes at 7 min and exhibited low levels of accumulation at the 
core regions. Instead, small foci of SIM3(EE) appeared in non-core regions at 9–11 min, 
the period during which WT lamin A accumulated at the core region. Furthermore, the 
SIM3(EE) mutant formed a number of small foci and appeared to be enriched at the 
proximal non-core regions of the telophase chromosomes.  
   Next, I transiently expressed HA-tagged wild type and SIM3(EE) lamin A in HeLa 
cells and examined the subcellular distributions of these proteins during cell cycle 
progression. Consistent with the results obtained using the GFP-labeled reporters, the 
distribution patterns of SIM3(EE) lamin A in interphase cells and in mitotic cells at 
prophase, prometaphase, metaphase, and anaphase were similar to those of wild type 
HA-lamin A, as well as to those of endogenous lamina A (data not shown). Notably, 
however, the SIM3(EE) mutant exhibited abnormal localization in cells at telophase. As 
shown in Fig. 2C, while endogenous lamin A/C and the transiently expressed HA-WT 
lamin A accumulated on telophase chromosomes and at the peripheral region of 
chromosomes, the SIM3(EE) mutant was not detected on the mitotic chromosomes and 
did not assemble into nuclear lamina at the peripheral region of chromosomes during 
telophase. These results suggest that SIM3 is required for the accumulation of lamin A 
on telophase chromosomes and for the reassembly of lamin A. To validate this hypothesis,  
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Fig. 2. Abnormal localization of the lamin A SUMO-interacting motif 3 (SIM3) mutant 
protein during mitosis. (A) HeLa cells were transfected with plasmids expressing HA-tagged 
lamin A proteins [wild type (WT), SIM1(EE), SIM2(EE), SIM3(EE), or SIM4(EE)], and 
visualized by confocal immunofluorescence microscopy at 24 h or 48 h after transfection. Bar, 
5 μm. The images are representative of cells examined in three independent experiments (24 
h, n > 5; 48 h, n > 20). (B) HeLa cells were transfected with plasmids expressing GFP-tagged 
WT, SIM2(EE), or SIM3(EE) and cultured for 22–30 h. Live images of cells were captured at 
1-min intervals until the end of cytokinesis using confocal microscopy. The time-lapse images 
obtained are shown from left to right, with time point 0 indicating the metaphase-anaphase 
transition. Bar, 10 μm. Note that WT lamin A and the SIM2(EE) mutant, but not the SIM3(EE) 
mutant, associated with telophase chromosomes at 7 min (indicated by arrows), and 
accumulated at the “core” region at 9 min (indicated by arrowheads). The images are 
representative of cells examined in at least two independent experiments (n > 3).  
A 
B 
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Fig. 2. Abnormal localization of the lamin A SUMO-interacting motif 3 (SIM3) mutant 
protein during mitosis. (C) Non-transfected HeLa cells and cells transfected with plasmids 
expressing HA-lamin A [WT, SIM3(EE) or SIM3(AA)] proteins were subjected to 
immunofluorescence staining using anti-lamin A/C or anti-HA antibodies (green) at 24 h 
post-transfection. DNA was stained with Hoechst 33258 dye (blue). Bar, 5 μm. Note that 
endogenous lamin A/C and HA-WT lamin A localized to telophase chromosomes 
(indicated by arrows), while the SIM3(EE) and (AA) mutant did not (indicated by 
arrowhead). The images are representative of cells examined in three independent 
experiments (n > 3). 
C 
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I created an additional SIM3 mutant in which two hydrophobic valine residues within the 
domain were substituted with alanine residues (SIM3[AA]), and examined the subcellular  
localization of this protein during telophase. Similar to SIM3(EE), SIM3(AA) did not 
accumulate on telophase chromosomes, supporting the requirement of SIM3 for 
accumulation of lamin A on telophase chromosomes. It should be noted that expression 
of the SIM3(EE) mutant did not prominently disturb the organization of the nuclear 
envelope, as determined by immunostaining of endogenous emerin, lamin B, RanBP2, 
and Nup153 during cytokinesis; however, the nuclear envelope exhibited an abnormal 
structure during the late G1 phase (Fig. 3). Moreover, the majority of cells transiently 
expressing SIM3(EE) ceased proliferating after only a few cycles of cell division (Fig. 4). 
Therefore, I speculate that SIM3 may be required for normal reorganization of the nuclear 
envelope. 
   Next, I utilized a set of GFP-fused lamin A deletion mutants to characterize the amino 
acid region that is sufficient for chromosomal targeting of lamin A during telophase (Fig. 
5A). Interestingly, the region comprising amino acids 417–572, which contains the C-
terminal Ig-fold domain and nuclear localization signal (NLS), was itself capable of 
effectively accumulating on telophase chromosomes (Fig. 5B), indicating that dimer 
formation through the α-helical rod domain at the N-terminus may be dispensable for 
lamin A accumulation on telophase chromosomes. Consistent with these findings, 
deletion of residues 417–572 (lamin A417–572/SIM3(EE)) abolished lamin A accumulation on 
the telophase chromosomes (Fig. 5C). Therefore, I concluded that the C-terminal 156 
amino acids are responsible for mediating lamin A accumulation on telophase 
chromosomes, and that SIM3 is crucial for this process.  
SIM3 plays an important role in the dephosphorylation of lamin A during telophase 
As described above, lamin A SIM3(EE) failed to accumulate on telophase chromosomes 
and to form a normal nuclear lamina. Because it was previously shown that 
phosphorylation and dephosphorylation of lamin A, particularly at Ser-22 (S22) and Ser-
392 (S392), are required for nuclear lamina disassembly and reassembly during mitosis, 
respectively (Heald and McKeon, 1990), I investigated the effects of the SIM3(EE) 
mutation on lamin A phosphorylation and dephosphorylation during mitosis. Fluctuations 
in the phosphorylation and localization of endogenous lamin A/C and HA-lamin A (WT  
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Fig. 3. The effects of a lamin A SUMO-interacting motif 3 (SIM3) mutant on the 
intracellular localization of emerin, lamin B1, RanBP2, and Nup153. HeLa cells were 
transfected with plasmids expressing HA-tagged wild type (WT) lamin A or lamin A 
SIM3(EE). At 28 h after transfection, the cells were fixed and stained with an anti-HA 
antibody (green), and with anti-emerin, anti-lamin B1, anti-RanBP2, or anti-Nup153 
antibodies (red). DNA was stained with Hoechst 33258 dye (blue). Confocal images of each 
phase of mitosis are shown (n > 3 for each mitosis stage). Bar, 5 μm.  
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Fig. 4. The effects of a lamin A SUMO-interacting motif 3 (SIM3) mutant on 
cell proliferation. (A) Untreated HeLa cells and cells transfected with plasmids 
expressing HA-tagged wild type (WT) lamin A or lamin A SIM3(EE) were fixed 
and stained with anti-HA, anti-phosphorylated lamin A/C (Ser22) antibodies, and 
Alexa Fluor 594- and 488-conjugated secondary antibodies, respectively, at 72 h 
post-transfection. DNA was stained with Hoechst 33258 dye (blue). Bar, 25 μm. 
(B) The numbers of cells expressing HA-lamin A relative to the number of non-
transfected cells are included in the graph. Three colonies of non-transfected cells 
and five colonies of transfected cells were measured. Data are shown as means ± 
standard errors of the mean (SEM). *p < 0.05 vs. WT.  
A 
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Fig. 5. Accumulation of lamin A deletion mutants on telophase chromosomes. 
(A) Schematic domain structure of the lamin A deletion mutants. Underline 
indicates that the deletion mutants exhibited accumulation on telophase 
chromosomes. Green colored dashed lines indicate the region responsible for 
accumulation on telophase chromosomes. (B and C) HeLa cells were transfected 
with plasmids expressing GFP-fused lamin A deletion mutant (B) or lamin A417–
572/SIM3(EE) mutant (C), and fixed at 27 h after transfection. The images were 
obtained by confocal fluorescence microscopy. The 384–664, 417–664, 384–572, 
and 417–572 deletion mutants (indicated by arrows), but not the 1–383, 423–664, 
436–664, 384–544 and 417–572/SIM3(EE) deletion mutants, exhibited 
chromosomal localization during telophase. Bar, 5μm. The images are 
representative of cells examined in three independent experiments (n > 3).  
A B 
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and SIM3[EE]) during mitosis were monitored by immunofluorescence staining using an 
antibody specific for lamin A/C phosphorylated at serine 22 (pS22) (Fig. 6A). For detailed  
observation, I divided telophase into two definitive phases (telophase I and telophase II) 
based on chromosomal morphology and the presence or absence of prenucleolar bodies 
(Savino et al., 2001; Carron et al., 2012), as depicted in Fig. 7. There was no difference 
in lamin A pS22 localization between non-transfected cells and cells expressing HA-WT 
lamin A. Lamin A pS22 signals appeared in the nucleoplasm concurrently with the 
beginning of prophase, and were dispersed in the cytoplasm until entry into telophase. 
Notably, pS22 signals promptly accumulated on chromosomes in telophase I, and then 
decreased as telophase progressed. Meanwhile, the subcellular localization pattern of 
pS22 in HeLa cells expressing the SIM3(EE) mutant were quite similar to those in HeLa 
cells with or without HA-WT lamin A during prophase, prometaphase, metaphase, and 
anaphase. However, the accumulation of pS22 on telophase chromosomes was not 
observed in cells expressing SIM3(EE). Moreover, highly intense pS22 signals remained 
throughout the latter phase of telophase (telophase II) and cytokinesis (Fig. 4A), and 
SIM3(EE) expression resulted in markedly increased numbers of p22-positive interphase 
cells at 72 h after transfection (Fig. 6D). These results suggest that, in addition to its role 
in promoting the accumulation of lamin A on telophase chromosomes, SIM3 is required 
for proper dephosphorylation of lamin A at the end of mitosis. 
   Because lamin A dephosphorylation during late mitosis seemed to be inhibited by 
expression of the SIM3(EE) mutant, I next quantified changes in the levels of lamin A 
pS22 during mitosis by immunoblot analysis. For these analyses, HeLa cells were 
transfected with plasmids expressing HA-tagged WT lamin A or SIM3(EE) and 
synchronized at the beginning of mitosis, according to the protocol illustrated in Fig. 4B. 
Cells were collected by shaking, transferred to fresh medium, harvested, and lysed at 
various time points. Synchronization and cell cycle progression were evident by 
fluctuations in cyclin B1 expression levels (Fig. 6C). Dephosphorylation of HA-WT 
lamin A was clearly observed at 1.5 h after release from the nocodazole block. In contrast, 
I detected scarce amounts of dephosphorylation of lamin A in cells expressing SIM3(EE) 
at 1.5 h after the release from mitotic arrest, and the relative amount of pS22 in cells 
expressing SIM3(EE) was approximately four-fold higher than that in cells expressing  
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Fig. 6. Effect of the SUMO-interacting motif 3 (SIM3) (EE) mutation on the 
phosphorylation/dephosphorylation of lamin A. (A) Upper panel: HeLa cells were 
stained using anti-lamin A/C (endo LA/C; green) and anti-phosphorylated lamin A/C 
(Ser22) (LA/C pS22; red) antibodies. Middle and lower panels: HeLa cells were 
transfected with plasmids expressing HA-tagged wild type (WT) lamin A or lamin A 
SIM3(EE). At 28 h after transfection, the cells were fixed and stained using anti-HA 
(green) and anti-LA/C pS22 (red) antibodies. DNA was stained with Hoechst 33258 dye 
(blue). Confocal images of each phase of mitosis are shown. Bar, 5 μm. Note that lamin 
A/C pS22 accumulated on telophase chromosomes in non-transfected cells and in cells 
expressing HA-WT lamin A (indicated by arrow), but not in 86.6% of fifteen cells 
expressing HA-lamin A SIM3(EE) (indicated by arrowhead). 
A 
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Fig. 6. Effect of the SUMO-interacting motif 3 (SIM3) (EE) mutation on the 
phosphorylation/dephosphorylation of lamin A. (B) Schematic depiction of the 
synchronization method. (C) HeLa cells transiently expressing HA-WT lamin A 
or HA-lamin A SIM3(EE) were synchronized in mitosis, as described in B. Cells 
were then collected and directly lysed in Laemmli sample buffer at the indicated 
time points after release from the blockage. The samples were then subjected to 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and 
proteins were detected by western blot analysis using anti-LA/C pS22, pan-lamin 
A/C (pan-LA) and anti-cyclin B1 antibodies. The graph on the right summarizes 
the results of the quantification of phosphorylated lamin A band signals. The 
values denote the ratio of the phosphorylation signal intensity normalized to the 
Coomassie brilliant blue (CBB)-stained proteins at each time point, compared to 
that in the 0 h sample. The data is representative of two independent experiments 
with similar results. (D) The percentages of the number of LA/C pS22-positive 
cells during interphase are shown in the graph. Non-transfected HeLa cells and 
cells transfected with plasmids expressing HA-wild type (WT) lamin A or 
SIM3(EE) were fixed at 72 h post-transfection and stained with anti-HA and anti-
LA/C pS22 antibodies, and Alexa Fluor 594 and 488-conjugated secondary 
antibodies, respectively. Non-transfected or transfected cells were analyzed using 
ImageJ software (HeLa; n = 102, WT; n = 58, SIM3(EE); n = 36). Quantification 
of phosphorylation-positive cells number was performed using the ImageJ 
threshold/analyze particle features (threshold: 30–255). Data are shown as means 
± standard errors of the mean (SEM). *p < 0.05 vs. WT. 
B 
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Fig. 7. Representative images of telophase I and telophase II. During telophase 
I, the chromosome arms, but not the prenucleolar body or nucleolus, are visible. 
In telophase II, the chromosome arms disappear and prenucleolar bodies (arrows), 
which are known to appear at the end of telophase, are visible. Bar, 5 μm. 
61 
 
WT lamin A at 3.0 h. Again, these findings demonstrate the significance of SIM3 for 
proper lamin A dephosphorylation at the end of mitosis. 
Expression of a conjugation-defective SUMO2 mutant inhibits the localization of 
lamin A to telophase chromosomes 
Given the significance of SIM3 for proper lamin A dynamics during the later phase of 
mitosis, I speculated that SIM-mediated interactions between unknown SUMOylated 
protein(s) and lamin A would be involved in lamin A accumulation on telophase 
chromosomes. To explore this possibility, I first examined whether endogenous SUMO1 
and SUMO2/3 colocalized with lamin A on telophase chromosomes. As shown in Fig. 8A 
and C, while SUMO1 partially localized to the region surrounding the telophase 
chromosomes, it did not colocalize with lamin A/C on the chromosomes during this 
period. In contrast, SUMO2/3 began to accumulate on the chromosomes in telophase I 
(Fig. 8B). Since lamin A pS22 also accumulated on chromosomes during telophase I (Fig. 
6A), I measured the levels of colocalization between lamin A/C pS22 and SUMO2/3 by 
quantitative colocalization analysis of confocal immunofluorescence images using Fiji 
software (Fig. 8C and D). Although colocalization signals (white color signals) were 
scarcely detected in cells during prophase or anaphase, significant levels of partial 
colocalization were detected in cells during telophase I (Fig. 8C and D). 
   To obtain further evidence for the participation of SUMOylated protein(s) in lamin A 
accumulation on telophase chromosomes, I generated an expression plasmid encoding 
the SUMO2 (G93A) mutant, which cannot covalently bind to target proteins, and has 
been shown to inhibit endogenous SUMOylation in a dominant-negative manner (Li et 
al., 2003; Schou et al., 2014). I examined the effects of G93A expression on the 
localization pattern of WT lamin A in telophase I by simultaneously expressing HA-WT 
lamin A and myc-SUMO2 (WT or G93A) in HeLa cells (Fig. 9A). Surprisingly, while 
abundant myc-SUMO1 (WT) was detected on telophase chromosomes, only scant 
chromosomal localization of myc-SUMO2 (G93A) was observed. Given that G93A is 
incapable of conjugating to target proteins, the myc-SUMO2 (WT) signals on telophase 
chromosomes may correspond to protein(s) conjugated to myc-SUMO2. Expression of 
G93A, but not WT SUMO2, impaired the accumulation of WT lamin A on telophase 
chromosomes as well as the reassembly of lamin A at peripheral chromosomal regions.  
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Fig. 8. Lamin A/C colocalizes with SUMO2/3 on telophase chromosomes. HeLa cells 
were double-stained with anti-lamin A/C (green) and anti-SUMO1 (A; red) or anti-
SUMO2/3 (B; red) antibodies. The confocal images depict cells at each stage of mitosis. 
DNA was stained with Hoechst 33258 dye (blue). Bar, 5 μm. The images are representative 
of cells examined in two independent experiments (n > 3 for each mitosis stage). 
A 
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Fig. 8. Lamin A/C colocalizes with SUMO2/3 on telophase chromosomes. (C) 
HeLa cells were synchronized in mitosis using a nocodazole block. At 1.5 h after 
release from mitotic arrest, cells were subjected to immunofluorescence staining 
using antibodies specific to lamin A/C phosphorylated at Ser22 (LA/C pS22) and 
to SUMO2/3 (magenta). Representative images of cells during prophase, 
anaphase, or in telophase I are shown. Enlarged images within the white rectangle 
are shown in bottom panels. Partial colocalization of the LA/C pS22 and 
SUMO2/3 signals (white color) was observed in cells in telophase I. Bar, 5 μm. 
(D) Analysis of colocalization of LA/C pS22 and SUMO2/3 signals in cells during 
prophase, anaphase, or in telophase I. The means ± standard errors of the mean 
(SEM) of the Pearson’s correlation coefficient from cells (prophase, 9 cells; 
anaphase, 7 cells; telophase I, 10 cells) are provided. ***p < 0.0005. 
C D 
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Fig. 9. Effect of the conjugation-defective small ubiquitin-related modifier 2 
(SUMO2) mutant on lamin A localization. (A) HeLa cells were simultaneously 
transfected with plasmids expressing HA-lamin A and either wild type (WT) 
SUMO2 (n = 9) or the conjugation-defective SUMO2 (G93A) mutant (n = 4). At 
28 h after transfection, the cells were fixed and double-stained with anti-HA 
(green) and anti-myc antibodies. DNA was stained with Hoechst 33258 dye (blue). 
Confocal images of cells in telophase I are shown. Bar, 5 μm. (B) HeLa cells were 
simultaneously transfected with plasmids expressing HA-lamin A and either WT 
SUMO2 (n = 11) or SUMO2 (G93A) (n = 5). At 28 h after transfection, the cells 
were fixed and double-stained with anti-HA and anti-phosphorylated lamin A/C 
(Ser22) (green) antibodies. DNA was stained with Hoechst 33258 dye (blue). 
Confocal images of cells in telophase I are shown. Bar, 5 μm. 
A B 
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Fig. 10. Effect of the conjugation-defective small ubiquitin-related modifier 1 
(SUMO1) mutant on the localization of lamin A and the lamin A K201R 
mutant in telophase I. (A) HeLa cells were simultaneously transfected with 
plasmids expressing HA-lamin A and either myc-wild type (WT) SUMO1 or the 
conjugation-defective myc-SUMO1 (G97A) mutant. At 28 h after transfection, 
the cells were fixed and stained with HA- (green) and myc-specific antibodies. 
DNA was stained with Hoechst 33258 dye (blue). Bar, 5 μm. The images are 
representative of more than three cells. (B) HeLa cells expressing HA-lamin A 
K201R were subjected to immunofluorescence staining using an anti-HA antibody 
(HA-LA [K201R]; green). DNA was stained with Hoechst 33258 dye. Bar, 5 μm. 
The images are representative of more than three cells. 
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Additionally, chromosomal accumulation of lamin A pS22 was not observed in cells 
expressing SUMO2 (G93A) (Fig. 9B). Notably, however, expression of the conjugation-  
defective myc-SUMO1 (G97A) mutant had no effect on lamin A localization during 
telophase (Fig. 10A). Together, these results indicate that the chromosomal accumulation 
of lamin A pS22 during telophase may depend on the presence of a SUMO2-modified 
protein(s) that is already associated with the chromosomes. 
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3-6. Discussion 
In this report, I demonstrated that the C-terminal 156 amino acids of lamin A, which 
contains an NLS and an Ig-fold domain, are involved in the normal accumulation of lamin 
A on telophase chromosomes. These findings are therefore consistent with those of a 
previous report demonstrating that this region of lamin A is responsible for chromatin or 
DNA binding (Taniura et al., 1995; Stierlé et al., 2003). I also provided evidence that 
SIM3, located within the Ig-fold, plays a crucial role in the spatiotemporal regulation of 
dephosphorylation of lamin A during telophase. To the best of our knowledge, this is the 
first report of a SUMO-SIM interaction that is involved in the spatiotemporal regulation 
of dephosphorylation. 
   Analysis of an alignment of various SIM-containing regions revealed that the majority 
of these motifs contain a stretch of acidic amino acids adjacent to the SIM. In contrast, 
there are no neighboring acidic amino acid stretches near the N- or C-terminal region of 
the SIM3 motif of lamin A. A similar type of SIM was reported in TRAF and TNF 
receptor-associated protein (TTRAP) (Hecker et al., 2006). Interestingly, TTRAP was 
shown to interact with SUMO2 preferentially to SUMO1. Consistent with these findings, 
our GST pull-down experiments showed that lamin A exhibited higher affinity for 
SUMO2/3 than for SUMO1 in vitro. Together, these findings suggest that the absence of 
stretches of acidic amino acids adjacent to the SIM may promote the preference for 
SUMO2 in both TTRAP and lamin A.  
   Detailed immunofluorescence analyses revealed that phosphorylated lamin A/C 
transiently accumulated on condensed chromosomes during early telophase, after which 
the majority of the signal quickly disappeared prior to the beginning of cytokinesis. 
Interestingly, nuclear lamina reorganization occurred shortly after the disappearance of 
phosphorylated lamin A from the telophase chromosomes, implying that 
dephosphorylation of lamin A/C may occur on the condensed chromosomes during early 
telophase. I also found that mutation of SIM3 abolished the localization of lamin A to 
telophase chromosomes in vivo, as well as the interaction between lamin A and SUMO2 
in vitro. Moreover, I found that this mutation caused a delay or defect in lamin A 
dephosphorylation, which is required for the assembly of the nuclear lamina. These 
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results suggest that this delay/defect is the result of the failed association between lamin 
A and the chromosomes during telophase I. 
   My data also demonstrate that inhibition of SUMOylation via expression of the 
dominant-negative SUMO2 (G93A) mutant impaired the chromosomal targeting of lamin 
A during early telophase. Considering that previous reports have shown that lamin A is 
modified with SUMO2 at K201 (Zhang and Sarge, 2008; Moriuchi et al., 2014), it is 
possible that defects in the SUMOylation of the lamin A polypeptide itself caused this 
phenotype. However, because the K201R lamin A mutant, which is not SUMOylated at 
K201, exhibited normal assembly on telophase chromosomes (Fig. S4B), I excluded this 
possibility. Therefore, it is probable that the SUMO-interacting function of SIM3 is 
responsible for the binding of lamin A to telophase chromosomes. Moreover, I 
hypothesize that phosphorylated lamin A is recruited to telophase chromosomes through 
an interaction with a chromatin-binding protein(s) modified with SUMO2, and is 
subsequently dephosphorylated on the chromosomes during telophase; however, the 
identification of such a recruiting protein is necessary to further characterize the 
mechanism governing the organization of the nuclear lamina at the end of mitosis. Recent 
quantitative proteomics approaches, such as stable isotope labeling by amino acids in cell 
culture (SILAC), using cells synchronized at different cell-cycle stages have uncovered 
SUMO2/3-modified proteins during mitosis that contain several chromatin-binding 
factors (Schimmel et al., 2014; Schou et al., 2014). Indeed, Cubeñas-Potts et al. (2015) 
purified and identified 149 distinct SUMO2/3-modified proteins from mitotic 
chromosomes. In addition, I have considered several other putative SUMOylation-
dependent lamin A-binding proteins: BAF, emerin, PP1γ, and the phosphatase interactor 
Repo-Man (Moorhead et al., 2007; Haraguchi et al., 2008). Interestingly, each of these 
candidates contains a consensus amino acid sequence for SUMOylation. Notably, in 
contrast to our conclusion regarding SIM3 function, structural analyses of the Ig-fold of 
lamin A by NMR and X-ray crystallography imply that SIM3 is located within a β strand 
that contributes to the formation of a β sandwich that exhibits low solvent accessibility 
(Krimm et al., 2002; Dhe-Paganon et al., 2002). I am therefore interested in the molecular 
mechanism underlying the interaction between SIM3 and SUMO or SUMOylated 
protein(s). I speculate that post-translational modification of lamin A, such as mitosis-
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specific phosphorylation and/or interaction with certain binding proteins, as mentioned 
above, results in a conformational change that increases the solvent accessibility of the 
SIM3 region. To address this contradiction, identification of factor(s) that bind to lamin 
A through SIM-SUMO interaction and detailed analyses of these binding properties are 
needed. 
   It was previously reported that the reassembly of A- and B-type lamins is governed 
by distinct mechanisms (Haraguchi et al., 2008). Consistent with this finding, I observed 
that the reassembly of lamin B was not affected by expression of the SIM3 mutant through 
the end of cytokinesis. SIM3, which is uniquely present in the A-type lamins, may 
therefore contribute to the regulation of lamin A-specific reassembly. Meanwhile, I 
observed abnormal organization of the nuclear envelope, including lamin B and the 
nuclear pore complex, in HeLa cells expressing the SIM3 mutant after cell division. These 
results support previous reports indicating that the organization of nuclear envelope 
complexes is completed in early G1 (Clever et al., 2013; Kind et al., 2013) through direct 
and/or indirect interactions among LEM-domain proteins, nuclear pore complex proteins, 
A- and B-type lamins, and chromatin (Shumaker et al., 2001; Clever et al., 2013).  
   In conclusion, I have demonstrated that phosphorylated lamin A associates with 
telophase chromosomes via an interaction between SIM3 and a chromatin-binding 
protein(s) modified with SUMO2, after which the protein is dephosphorylated (Fig. 11). 
My findings indicate that this SUMO-SIM interaction facilitates the reassembly of the 
nuclear lamina around the daughter chromosomes, and thus provide novel insights into 
this important process.  
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